10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
65.05
+5.77 (9.73%)
Nov 9, 2026, 4:00 PM EST - Market closed

10x Genomics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
526.19473.97344.07359.28219.75587.45
Short-Term Investments
49.4949.4449.3429.41210.24-
Cash & Short-Term Investments
575.68523.41393.4388.7429.98587.45
Cash Growth
19.41%33.05%1.21%-9.60%-26.80%-11.48%
Accounts Receivable
55.747.0187.86114.83104.2185.25
Other Receivables
3.0635.480.61---
Receivables
58.7682.4988.47114.83104.2185.25
Inventory
64.6356.3483.1173.7181.6359.97
Prepaid Expenses
19.5722.2119.4118.7916.5813.9
Restricted Cash
----2.631.03
Total Current Assets
718.63684.45584.39596.02635.04747.59
Property, Plant & Equipment
265287.16309.94344.93359.21230.41
Goodwill
6.924.514.514.514.514.51
Other Intangible Assets
58.6662.3315.6716.6222.8625.4
Other Long-Term Assets
13.922.914.133.067.3710.92
Total Assets
1,0631,041918.64965.141,0291,019

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
21.5912.7312.9115.7421.617.35
Accrued Expenses
49.7951.8952.0745.9851.953.27
Current Portion of Leases
11.9510.999.2911.529.045.13
Current Income Taxes Payable
6.987.224.945.054.084.62
Current Unearned Revenue
22.9623.920.6613.157.875.34
Other Current Liabilities
27.1146.7317.7735.7336.4824.64
Total Current Liabilities
140.37153.45117.63127.16130.96110.36
Long-Term Leases
63.8573.3873.3383.8586.1476.85
Long-Term Unearned Revenue
8.5310.512.518.813.17-
Other Long-Term Liabilities
12.357.715.034.282.9814.05
Total Liabilities
225.09245.04208.5224.1223.24201.26

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
2,3992,3072,1782,0261,8391,681
Retained Earnings
-1,561-1,511-1,467-1,284-1,029-863.32
Comprehensive Income & Other
0.20.23-0.49-0.43-4.340.02
Total Common Equity
838.04796.33710.13741.04805.74817.57
Shareholders' Equity
838.04796.33710.13741.04805.74817.57
Total Liabilities & Equity
1,0631,041918.64965.141,0291,019

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
75.7984.3682.6195.3795.1881.98
Net Cash (Debt)
499.89439.05310.79293.33334.81505.47
Net Cash Growth
26.52%41.27%5.95%-12.39%-33.76%-15.84%
Net Cash Per Share
3.883.522.582.502.944.58
Filing Date Shares Outstanding
131.53127.75122.3119.17115.36112.84
Total Common Shares Outstanding
131.49127.69122.29119.1115.2112.51
Working Capital
578.26531466.75468.86504.08637.23
Book Value Per Share
6.376.245.816.226.997.27
Tangible Book Value
772.46729.49689.95719.92778.37787.66
Tangible Book Value Per Share
5.875.715.646.046.767.00
Land
36.7736.7736.7736.7736.7836.1
Buildings
147.61147.49147.09146.04--
Machinery
106.95103.2697.0496.676.8762.69
Construction In Progress
2.612.935.157.2515352.19
Leasehold Improvements
91.0789.7289.5796.4191.5267.53
SEC Filings: 10-K · 10-Q